Health News Review
  • Nov 6 2012

    An unusual TV news sweeps period piece: profile of an evidence-based doc

    “You’ve probably never heard of Dr. Tim Wilt. He doesn’t have a TV show.  No advice column in the newspaper.” That’s how my friend (and former graduate student) Jeff Baillon of KMSP-TV began his 5 1/2 minute TV news sweeps period piece last night about Dr. Tim Wilt of the Minneapolis VA – a member [...]

    3 Comments
  • Nov 5 2012

    Proton Beam Therapy: evaluating claims in ASTRO papers of “excellent” quality of life data

    Last week, the American Society for Radiation Oncology’s annual conference was held in Boston, and several papers were presented on proton beam therapy, and several medical centers sent out news releases about their involvement in the work.  MD Anderson Cancer Center in Houston  and Loma Linda University Medical Center in California were two that we [...]

    3 Comments
  • Nov 1 2012

    “Keep some healthy skepticism about claims for silver bullets, perfect cures, and huge effects”

    My enthusiasm for the work of Dr. John Ioannidis of Stanford is shared by Harold DeMonaco, one of our story reviewers on HealthNewsReview.org.  DeMonaco submitted the following guest blog post, which I’m pleased to publish: ——————————————— The headline of this post is a quote from a recent interview that Gary pointed to in a recent [...]

    4 Comments
  • Oct 24 2012

    Ioannidis evidence-based medicine update

    Readers of this blog know that I frequently point readers to the work of John Ioannidis, MD, DSc, chief of the Stanford Prevention Research Center.   Here are several updated items in the news: A Stanford Med School blog published a piece, “Tropical disease treatments need more randomized, controlled trials,” citing an analysis published in [...]

    No Comments
  • Oct 5 2012

    Potpourri: What is AHA smoking? Will flu shots keep you healthy? Why do some oppose comparative effectiveness research?

    Before we wrap up the week, here are some items published this week that we think readers of this blog will be interested in: Dr. Yoni Freedhoff writes, “I Want Some of What the American Heart Association is Smoking” – admonishing the AHA for partnering with Frito-Lay on a fundraiser. Public Citizen calls on the [...]

    No Comments
  • Aug 20 2012

    Welch: “for a large part of medical practice, we don’t know what works”

    Dr. Gil Welch of the Dartmouth Institute for Health Policy and Clinical Practice has an opinion column in the New York Times, “Testing What We Think We Know.”  Excerpts: “The truth is that for a large part of medical practice, we don’t know what works. But we pay for it anyway. Our annual per capita [...]

    2 Comments 1 Star
  • Aug 16 2012

    George Lundberg: All Hail the US Preventive Services Task Force

    MedPage Today Editor-at-Large George Lundberg, MD writes about why, since 1986 when he was JAMA editor, he has been a “great fan” of the US Preventive Services Task Force: “USPSTF reports are one of the few, and at that early time, one of the only sources of important medical information that was influenced little or [...]

    No Comments 1 Star
  • Jul 20 2012

    Screening tests a focus of this year’s Rocky Mountain Workshop on Evidence-Based Health Care

    I’m off to the Rockies next week to speak at and participate in The Rocky Mountain Workshop on How to Practice Evidence-Based Health Care at the invitation of Dr. Andy Oxman of the Norwegian Knowledge Centre for the Health Services in Oslo. This is the 14th annual workshop but this will be my first. I’ve [...]

    2 Comments 1 Star
  • Jul 5 2012

    Iain Chalmers on publication bias

    Iain Chalmers, British health-services researcher, and founder of the Cochrane Collaboration, recently wrote a column, “Publish or Perish.”  Excerpts: “…failure to publish research results is by far the most common and worrying form of scientific and ethical misconduct in health research – and it has had lethal consequences. Anecdotal evidence of publication bias has existed [...]

    No Comments 1 Star
  • Jun 20 2012

    Welcome to Wonderland: another view on two hot-selling drug classes

    Statins and clotbusting thrombolytics are two of the hottest selling drug classes. But Dr, David Newman takes a closer look at each on his SMART Em blog (acronym for Scientific Medicine and Research Translation). A few weeks ago, he wrote about statin drugs for low-risk patients, “Data, Drugs and Deception:  A True Story.” And then [...]

    No Comments 1 Star